Nanomedicine for Cancer Treatment
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Drug Development".
Deadline for manuscript submissions: 31 July 2026 | Viewed by 12
Special Issue Editor
Special Issue Information
Dear Colleagues,
Cancer treatment continues to face significant challenges, including low drug selectivity, limited penetration into tumor tissues, and drug resistance. These limitations underscore the critical need for more accurate and effective therapeutic approaches.
Nanomedicine has emerged as a possible approach to overcoming these hurdles. Nanoparticles can be created to preferentially aggregate in tumor tissues, cross biological barriers, and take advantage of exclusively overexpressed cancer targets, which ultimately leads to increasing therapeutic outcomes and minimizing damage to healthy tissues.
The emergence of cancer immunotherapy, and the subsequent revolutionary discovery of immune checkpoint blockade, have opened up new vistas to treat difficult types of cancer where conventional chemotherapy is not successful. Meanwhile, nucleic acid-based therapeutics, gene-editing tools like CRISPR/CAS9, novel macromolecules and small molecules combinations, and specific molecular inhibitors remain as viable options for resistant cancers.
Combining the novel features that new cancer therapeutics provide with the versatility of nanomedicine is expected to dramatically improve the therapeutic outcomes achieved in cancer patients. Furthermore, nanotechnology-based diagnostic tools allow for earlier cancer diagnosis, imaging, and real-time monitoring of therapy responses.
In this Special Issue, we welcome original research and review articles exploring a wide range of topics on novel trends in personalized cancer nanomedicine including, but not limited to, nanodiagnostics, targeted delivery systems, and innovative nanotechnology-based chemo- and immunotherapies.
Dr. Youssef Wahib Naguib
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cancer nanomedicine
- CRISPR/CAS9 nanomedicine
- immune checkpoint inhibitors
- cancer immunotherapy
- targeted therapeutics
- targeted nanoparticles
- cell-penetrating peptides
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
